190 related articles for article (PubMed ID: 10374881)
1. APS, an adaptor protein containing Pleckstrin homology (PH) and Src homology-2 (SH2) domains inhibits the JAK-STAT pathway in collaboration with c-Cbl.
Wakioka T; Sasaki A; Mitsui K; Yokouchi M; Inoue A; Komiya S; Yoshimura A
Leukemia; 1999 May; 13(5):760-7. PubMed ID: 10374881
[TBL] [Abstract][Full Text] [Related]
2. APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis.
Yokouchi M; Wakioka T; Sakamoto H; Yasukawa H; Ohtsuka S; Sasaki A; Ohtsubo M; Valius M; Inoue A; Komiya S; Yoshimura A
Oncogene; 1999 Jan; 18(3):759-67. PubMed ID: 9989826
[TBL] [Abstract][Full Text] [Related]
3. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
4. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
5. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
[TBL] [Abstract][Full Text] [Related]
6. Repression of c-Cbl leads to enhanced G-CSF Jak-STAT signaling without increased cell proliferation.
Wang L; Rudert WA; Loutaev I; Roginskaya V; Corey SJ
Oncogene; 2002 Aug; 21(34):5346-55. PubMed ID: 12149655
[TBL] [Abstract][Full Text] [Related]
7. A new protein containing an SH2 domain that inhibits JAK kinases.
Endo TA; Masuhara M; Yokouchi M; Suzuki R; Sakamoto H; Mitsui K; Matsumoto A; Tanimura S; Ohtsubo M; Misawa H; Miyazaki T; Leonor N; Taniguchi T; Fujita T; Kanakura Y; Komiya S; Yoshimura A
Nature; 1997 Jun; 387(6636):921-4. PubMed ID: 9202126
[TBL] [Abstract][Full Text] [Related]
8. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
[TBL] [Abstract][Full Text] [Related]
9. Cbl functions downstream of Src kinases in Fc gamma RI signaling in primary human macrophages.
Erdreich-Epstein A; Liu M; Kant AM; Izadi KD; Nolta JA; Durden DL
J Leukoc Biol; 1999 Apr; 65(4):523-34. PubMed ID: 10204582
[TBL] [Abstract][Full Text] [Related]
10. The signal transduction through Grb2/Ash in hematopoietic cells.
Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H
Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406
[TBL] [Abstract][Full Text] [Related]
11. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
Arcasoy MO; Harris KW; Forget BG
Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2, and Cbl in hematopoietic cells.
Chin H; Saito T; Arai A; Yamamoto K; Kamiyama R; Miyasaka N; Miura O
Biochem Biophys Res Commun; 1997 Oct; 239(2):412-7. PubMed ID: 9344843
[TBL] [Abstract][Full Text] [Related]
14. A common epitope is shared by activated signal transducer and activator of transcription-5 (STAT5) and the phosphorylated erythropoietin receptor: implications for the docking model of STAT activation.
Barber DL; Beattie BK; Mason JM; Nguyen MH; Yoakim M; Neel BG; D'Andrea AD; Frank DA
Blood; 2001 Apr; 97(8):2230-7. PubMed ID: 11290583
[TBL] [Abstract][Full Text] [Related]
15. Functional effects of APS and SH2-B on insulin receptor signalling.
Ahmed Z; Pillay TS
Biochem Soc Trans; 2001 Aug; 29(Pt 4):529-34. PubMed ID: 11498022
[TBL] [Abstract][Full Text] [Related]
16. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta.
Rui L; Gunter DR; Herrington J; Carter-Su C
Mol Cell Biol; 2000 May; 20(9):3168-77. PubMed ID: 10757801
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of APS, an adaptor molecule containing PH and SH2 domains that is tyrosine phosphorylated upon B-cell receptor stimulation.
Yokouchi M; Suzuki R; Masuhara M; Komiya S; Inoue A; Yoshimura A
Oncogene; 1997 Jul; 15(1):7-15. PubMed ID: 9233773
[TBL] [Abstract][Full Text] [Related]
18. c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription.
Goh EL; Zhu T; Leong WY; Lobie PE
Endocrinology; 2002 Sep; 143(9):3590-603. PubMed ID: 12193575
[TBL] [Abstract][Full Text] [Related]
19. Association of JAK2 and STAT5 with erythropoietin receptors. Role of receptor phosphorylation in erythropoietin signal transduction.
Sawyer ST; Penta K
J Biol Chem; 1996 Dec; 271(50):32430-7. PubMed ID: 8943308
[TBL] [Abstract][Full Text] [Related]
20. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation.
Endo T; Sasaki A; Minoguchi M; Joo A; Yoshimura A
J Biochem; 2003 Jan; 133(1):109-13. PubMed ID: 12761205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]